AT405135B - Präparation umfassend thiolgruppen-hältige proteine - Google Patents

Präparation umfassend thiolgruppen-hältige proteine Download PDF

Info

Publication number
AT405135B
AT405135B AT0006897A AT6897A AT405135B AT 405135 B AT405135 B AT 405135B AT 0006897 A AT0006897 A AT 0006897A AT 6897 A AT6897 A AT 6897A AT 405135 B AT405135 B AT 405135B
Authority
AT
Austria
Prior art keywords
proteins
nitrosation
preparation
pharmaceutical preparation
protein
Prior art date
Application number
AT0006897A
Other languages
German (de)
English (en)
Other versions
ATA6897A (de
Inventor
Guenther Schlag
Seth Dr Hallstroem
Harald Gasser
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Ag filed Critical Immuno Ag
Priority to AT0006897A priority Critical patent/AT405135B/de
Priority to AT98890014T priority patent/ATE262917T1/de
Priority to EP98890014A priority patent/EP0853944B1/fr
Priority to DE59811071T priority patent/DE59811071D1/de
Priority to US09/008,583 priority patent/US6124255A/en
Publication of ATA6897A publication Critical patent/ATA6897A/de
Application granted granted Critical
Publication of AT405135B publication Critical patent/AT405135B/de
Priority to US09/610,111 priority patent/US6358918B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
AT0006897A 1997-01-17 1997-01-17 Präparation umfassend thiolgruppen-hältige proteine AT405135B (de)

Priority Applications (6)

Application Number Priority Date Filing Date Title
AT0006897A AT405135B (de) 1997-01-17 1997-01-17 Präparation umfassend thiolgruppen-hältige proteine
AT98890014T ATE262917T1 (de) 1997-01-17 1998-01-15 Präparation umfassend thiolgruppen-haltige proteine
EP98890014A EP0853944B1 (fr) 1997-01-17 1998-01-15 Préparations contenant des protéines à groupements thiol
DE59811071T DE59811071D1 (de) 1997-01-17 1998-01-15 Präparation umfassend Thiolgruppen-haltige Proteine
US09/008,583 US6124255A (en) 1997-01-17 1998-01-16 Preparation comprising thiol-group-containing proteins
US09/610,111 US6358918B1 (en) 1997-01-17 2000-07-05 Preparation comprising thiol-group-containing proteins

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0006897A AT405135B (de) 1997-01-17 1997-01-17 Präparation umfassend thiolgruppen-hältige proteine

Publications (2)

Publication Number Publication Date
ATA6897A ATA6897A (de) 1998-10-15
AT405135B true AT405135B (de) 1999-05-25

Family

ID=3480687

Family Applications (2)

Application Number Title Priority Date Filing Date
AT0006897A AT405135B (de) 1997-01-17 1997-01-17 Präparation umfassend thiolgruppen-hältige proteine
AT98890014T ATE262917T1 (de) 1997-01-17 1998-01-15 Präparation umfassend thiolgruppen-haltige proteine

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT98890014T ATE262917T1 (de) 1997-01-17 1998-01-15 Präparation umfassend thiolgruppen-haltige proteine

Country Status (4)

Country Link
US (2) US6124255A (fr)
EP (1) EP0853944B1 (fr)
AT (2) AT405135B (fr)
DE (1) DE59811071D1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT405135B (de) * 1997-01-17 1999-05-25 Immuno Ag Präparation umfassend thiolgruppen-hältige proteine
DE19926475A1 (de) * 1999-06-10 2000-12-14 Ktb Tumorforschungs Gmbh Träger-Pharmaka-Konjugate
CA2509817C (fr) * 2002-12-12 2014-11-04 Duke University Formation d'hemoglobine de nitrosyle de fer
AU2003300544A1 (en) * 2003-01-09 2004-08-10 F. Hoffmann-La Roche Ag -modified nucleoside derivatives for treating flaviviridae infections
FR2856591B1 (fr) * 2003-06-27 2005-10-14 Oreal Composition cosmetique a base de sel(s) de nitrosonium pour la deformation permanente des fibres keratiniques.
WO2005040197A1 (fr) * 2003-10-24 2005-05-06 Invitrogen Corporation Compositions, procedes et necessaires de marquage par fluorophores biarsenicaux
WO2005092362A2 (fr) * 2004-03-29 2005-10-06 Hallstroem Seth Preparation combinee therapeutique contenant une proteine therapeutique
US7187165B2 (en) * 2004-12-10 2007-03-06 Agilent Technologies, Inc. Method and system for implicitly encoding preferred probing locations in a printed circuit board design for use in tester fixture build
EP1976876A4 (fr) * 2005-12-22 2010-01-13 Conjuchem Biotechnologies Inc Procédé de production de conjugués d'albumine préformés et agent thérapeutique
CN116406374A (zh) * 2020-10-30 2023-07-07 深圳普罗吉医药科技有限公司 人血清白蛋白在治疗疾病中的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4540573A (en) * 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
AT389815B (de) * 1984-03-09 1990-02-12 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern in blutprodukten
AT390560B (de) * 1986-05-30 1990-05-25 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern
US4900719A (en) * 1988-08-05 1990-02-13 The Ohio State University Nitrosothiols as hypotensive agents
AT402789B (de) * 1991-03-25 1997-08-25 Immuno Ag Pharmazeutische präparation auf basis von plasmaproteinen
WO1994013329A1 (fr) * 1992-12-16 1994-06-23 Immuno Aktiengesellschaft Procede de preparation de compositions biologiques exemptes de virus
AT402788B (de) * 1993-08-03 1997-08-25 Immuno Ag Virussichere blutgerinnungsfaktor xiii-präparation
JPH09504274A (ja) * 1993-09-17 1997-04-28 ブリガム アンド ウィメンズ ホスピタル 人工表面および血管面の血栓を予防する酸化窒素付加物の利用
WO1996030006A1 (fr) * 1995-03-24 1996-10-03 Brigham And Women's Hospital Substituts sanguins nitrosyles
US5891735A (en) * 1995-09-15 1999-04-06 Duke University Medical Center Method for measuring nitric oxide in nitrosyl (FeII)-hemoglobin and S-nitrosohemoglobin
AT405135B (de) * 1997-01-17 1999-05-25 Immuno Ag Präparation umfassend thiolgruppen-hältige proteine

Also Published As

Publication number Publication date
EP0853944B1 (fr) 2004-03-31
EP0853944A3 (fr) 1999-10-27
ATA6897A (de) 1998-10-15
US6124255A (en) 2000-09-26
DE59811071D1 (de) 2004-05-06
EP0853944A2 (fr) 1998-07-22
US6358918B1 (en) 2002-03-19
ATE262917T1 (de) 2004-04-15

Similar Documents

Publication Publication Date Title
DE68907124T3 (de) Verfahren zum Stabilisieren von menschlichen Albuminlösungen und so erhaltene Lösung.
EP1136084B1 (fr) Compositions comprenant de la thrombine et procédé pour leur manufacture
DE3876600T2 (de) Plasma- und rekombinationsproteinformulierungen in einem milieu hoher ionenstaerke.
EP0447585B1 (fr) Procédé de production d'une préparation tolérante d'immunoglobuline G intraveineuse
DE69424545T2 (de) Verfahren zur herstellung von immunoglobulin g konzentrat
DE69701548T2 (de) Rekombinanten Faktor VIII enthaltendes stabilisiertes albuminfreies Präparat mit niedrigem Zuckergehalt
DE69231666T2 (de) Die nitrosylierung von enzym-sh gruppen als eine therapeutische massnahme
DE69130990T2 (de) Gereinigtes, virusfreies menschliches Thrombin
EP1753778B1 (fr) Procede pour purifier de l'erythropoietine
DE547932T1 (de) Verfahren zur Herstellung eines aktivierten Faktor VII-Konzentrates mit einer hohen Reinheit.
EP1153608A1 (fr) Préparation d'une protéine stable et son procédé de fabrication
EP0971958B2 (fr) PROCEDE DE PURIFICATION D'UN COMPLEXE FACTEUR VIII/FACTEUR DE VON WILLEBRAND (vWF) PAR CHROMATOGRAPHIE SUR ECHANGEUR DE CATIONS
AT406866B (de) Hochmolekulare und niedermolekulare fraktionen des von willebrand-faktors
AT405135B (de) Präparation umfassend thiolgruppen-hältige proteine
DE3825429A1 (de) Intravenoes verabreichbares polyklonales immunglobulin-praeparat mit hohem igm-gehalt und verfahren zu seiner herstellung
EP0413188A2 (fr) Procédé de préparation d'immunogluboline, non-modifiée contenant des IgM et/ou des IgA, administrables par voie intraveineuse
EP1012191B1 (fr) PROCEDE PERMETTANT D'OBTENIR UN FACTEUR DE VON WILLEBRAND (vWF) OU UN COMPLEXE FACTEUR VIII
DE4128319A1 (de) Neues rekombinantes human-ifn-beta, verfahren zu dessen herstellung und dieses enthaltende pharmazeutische zubereitungen
DE69221369T2 (de) Verfahren zur Herstellung eines Konzentrates von Blutgerinnungsfaktor XI mit hoher spezifischer Aktivität zur therapeutischen Verwendung
WO2005092362A2 (fr) Preparation combinee therapeutique contenant une proteine therapeutique
DE69231401T2 (de) Herstellung von faktor-ix
AT403765B (de) Verfahren zur herstellung einer präparation enthaltend einen hochgereinigten komplex
DE69426244T2 (de) Einen für Tumore cytotoxischen Faktor enthaltende pharmazeutische Zusammensetzung
EP0354354A2 (fr) Procédé de concentration des facteurs de coagulation du sang II, VII, IX en X
DE69303941T2 (de) Verfahren zur Herstellung von hochreinem Fibrinogen

Legal Events

Date Code Title Description
EIH Change in the person of patent owner
MK07 Expiry

Effective date: 20170117